Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical Prostatectomy

Takai, Tomoaki;Inamoto, Teruo;Komura, Kazumasa;Tsujino, Takuya;Matsunaga, Tomohisa;Yoshikawa, Yuki;Uchimoto, Taizo;Saito, Kenkichi;Tanda, Naoki;Minami, Koichiro;Uehara, Hirofumi;Ibuki, Naokazu;Takahara, Kiyoshi;Nomi, Hayahito;Kiyama, Satoshi;Azuma, Hayahito

  • Published : 2016.04.11


Background: We vigorously reviewed patients' operation record who had adhesion of the Denonvilliers' fascia and found out most of these patients had prostatic bleeding after prostatic gland biopsies. We examined the magnitude of prostatic bleeding and frequency after biopsies and the relationship with oncological outcomes. Materials and Methods: A total of 285 patients were selected for the final analyses. Inclusion criteria were as follows: receiving MRI three weeks after biopsiesand laparoscopic radical prostatectomy within 300 days after biopsy. We divided the patients into two groups with (group A) or without (group B) prostatic bleeding. We examined the magnitude of prostatic bleeding after biopsies and the relationship with operation time (OT), positive surgical margin (PSM), biochemical recurrence (BCR) and other factors. Furthermore, we created a logistic-regression model to derive a propensity score for prostatic bleeding after biopsies, which included all patient and hospital characteristics as well as selected interaction terms, and we examined the relationship with PSM and BCR. Results: In all patients, the OT in the group B was shorter than the group A (p < 0.001). Prostatic bleeding was associated with PSM (p=0.000) and BCR (p=0.036). In this propensity-matched cohort, 11 of 116 patients in the group B had PSM as compared with 36 of 116 patients from group A (match-adjusted odds ratio, 4.30; 95%CI confidence interval, 2.06 to 8.96; P=0.000). In addition, eight of 116 patients in group B encountered BCR, as compared with 18 of 116 patients in group A (match-adjusted odds ratio, 2.48; 95%CI, 1.03 to 5.96; P=0.042). Kaplan-Meier analysis in the propensity matching cohort showed a significant biochemical recurrence-free survival advantage for being free of prostate bleeding after biopsies. Conclusions: Our findings in the present cohort should help equip surgeons to pay attention to careful excision especially for those who experienced deferred prostatic bleeding.


Prostate cancer;laparoscopic radical prostatectomy;biopsy;MRI;bleeding


  1. Abbou CC, Salomon L, Hoznek A, et al (2000). Laparoscopic radical prostatectomy: preliminary results. Urol, 55, 630-4.
  2. Amling CL, Riffenburgh RH, Sun L, et al (2004). Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol, 22, 439-45.
  3. Boczko J, Madeb R, Golijanin D, et al (2006). Robot-assisted radical prostatectomy in obese patients. Can J Urol, 13, 3169-73.
  4. Boorjian SA, Crispen PL, Carlson RE, et al (2008). Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy. J Endourol, 22, 1471-6.
  5. Brown JA, Rodin DM, Lee B, et al (2005). Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases. J Urol, 173, 442-5.
  6. Chang IH, Byun SS, Hong SK, et al (2007). Assessing the body mass index of patients might help to predict blood loss during radical retropubic prostatectomy in Korean men. BJU Int, 99, 570-4.
  7. Chang SS, Duong DT, Wells N, et al (2004). Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index. J Urol, 171, 1861-5.
  8. D'Alonzo RC, Gan TJ, Moul JW, et al (2009). A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy. J Clin Anesth, 21, 322-8.
  9. Eden CG, Chang CM, Gianduzzo T, et al (2006). The impact of obesity on laparoscopic radical prostatectomy. BJU Int, 98, 1279-82.
  10. Freedland SJ, Aronson WJ, Kane CJ, et al (2004). Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared equal access regional cancer hospital database study group. J Clin Oncol, 22, 446-53.
  11. Freedland SJ, Grubb KA, Yiu SK, et al (2005). Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol, 174, 1798-801.
  12. Frota R, Turna B, Santos BM, et al (2008). The effect of prostate weight on the outcomes of laparoscopic radical prostatectomy. BJU Int, 101, 589-93.
  13. Herman MP, Raman JD, Dong S, et al (2007). Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy. Jsls, 11, 438-42.
  14. Hong SK, Kim DS, Lee WK, et al (2010). Significance of postbiopsy hemorrhage observed on preoperative magnetic resonance imaging in performing robot-assisted laparoscopic radical prostatectomy. World J Urol, 28, 721-6.
  15. Jayachandran J, Aronson WJ, Terris MK, et al (2008). Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the shared equal access regional cancer hospital database. BJU Int, 102, 964-8.
  16. Kaji Y, Kurhanewicz J, Hricak H, et al (1998). Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiol, 206, 785-90.
  17. Khaira HS, Bruyere F, O'Malley PJ, et al (2006). Does obesity influence the operative course or complications of robot-assisted laparoscopic prostatectomy. BJU Int, 98, 1275-8.
  18. Komaru A, Kamiya N, Suzuki H, et al (2010). Implications of body mass index in Japanese patients with prostate cancer who had undergone radical prostatectomy. Jpn J Clin Oncol, 40, 353-9.
  19. Lloyd JC, Banez LL, Aronson WJ, et al (2009). Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis, 12, 264-8.
  20. Martin GL, Nunez RN, Humphreys MD, et al (2009). Interval from prostate biopsy to robot-assisted radical prostatectomy: effects on perioperative outcomes. BJU Int, 104, 1734-7.
  21. Mikhail AA, Orvieto MA, Billatos ES, et al (2006). Robotic-assisted laparoscopic prostatectomy: first 100 patients with one year of follow-up. Urol, 68, 1275-9.
  22. Schuessler WW, Schulam PG, Clayman RV, et al (1997). Laparoscopic radical prostatectomy: initial short-term experience. Urol, 50, 854-7.
  23. Secin FP, Jiborn T, Bjartell AS, et al (2008). Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. Eur Urol, 53, 134-45.
  24. Tewari A, Sooriakumaran P, Bloch DA, et al (2012). Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol, 62, 1-15.
  25. White S, Hricak H, Forstner R, et al (1995). Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiol, 195, 385-90.